F1RST UP: Structured to accelerate your clinical trial.

F1RST UP is currently a US-based network of clinical investigators and research sites that sets the standard for study efficiency and effectiveness. Each of these sites can get your study up and running rapidly. Frenova’s near-term strategic goal is to expand the F1RST UP network globally.

We can quickly activate our F1RST UP network to enroll the most suitable patients for renal clinical trials or studies on adjacent or other conditions including cardiovascular disease, diabetes, depression, obesity. We can also enroll patients for clinical trials that involve rare diseases or vaccines.

Benefits of working with the Frenova F1RST UP network.

From day one, our team uses their deep expertise to navigate the complexities of trial feasibility, the IRB submission process, contracting, and budgeting.

Technology-enabled patient screening and a proprietary toolkit of specific agreements further streamline study start-up and administration.

Frenova offers data analytics and licensing services with access to one of nephrology’s largest longitudinal databases. It includes information on more than two million patients collected over 25 years by Fresenius Medical Care.

Because our clinical research coordinators are on site, they can communicate personally with study participants, consult with clinic staff, anticipate issues, and monitor progress.

When patient recruitment begins, our on-site clinical research coordinators can accelerate enrollment through their close relationships with physicians, patients, and the larger community.

Our clinical project manager is your single point of contact, delivering seamless communication throughout every phase of your clinical trial.

See what is takes to become a F1RST UP Site. 

Our team will help you streamline procedures, accelerate enrollment, and optimize your site’s performance.  

Meet the F1RST UP Team

The US-based F1RST UP network includes reputable thought leaders working in renal and renal-adjacent research today. These site investigators have an intimate understanding of how living with kidney disease and its comorbidities affect the lives of individuals and communities.